Characterization of Dendritic Cells and Myeloid-Derived Suppressor Cells Expressing Major Histocompatibility Complex Class II in Secondary Lymphoid Organs in Systemic Lupus Erythematosus-Prone Mice
Authors:
- Felipe R. UribeFUFelipe R. Uribe
- Fabián González-MartínezFGFabián González-Martínez
- Sebastián A. Echeverría-ArayaSESebastián A. Echeverría-Araya
- Alison Sepúlveda-PontigoASAlison Sepúlveda-Pontigo
- Karissa Chávez-VillacresesKCKarissa Chávez-Villacreses
- Andrés Díaz-BozoADAndrés Díaz-Bozo
- Isabel Méndez-PérezIMIsabel Méndez-Pérez
- Valentina P. I. GonzálezVGValentina P. I. González
- Karen BohmwaldKaren Bohmwald
- Alexis M. KalergisAKAlexis M. Kalergis
- Jorge A. SotoJorge A. Soto
Open Access
- 19 December 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13604
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by self-antibody production and widespread inflammation affecting various body tissues. This disease is driven by the breakdown of immune tolerance, which promotes the activation of autoreactive B and T cells. A key feature of SLE is dysregulation in antigen presentation, where antigen-presenting cells (APCs) play a central role in perpetuating immune responses. Dendritic cells (DCs) are highly specialized for antigen presentation among APCs. At the same time, myeloid-derived suppressor cells (MDSCs) can also express MHC-II molecules, although their role in SLE is less understood. Utilizing the SLE model, MRL/MpJ-Faslpr/J, we determined the presence of different phenotypes of DCs and MDSCs expressing MHC-II in secondary lymphoid organs, along with the gene expression of ICOSL, CD80 and CD86 in the spleen. Our study determined that the most abundant population of APCs in secondary lymphoid organs corresponds to cDC CD103−CD11b+ MHC-II+ throughout SLE development. Additionally, ICOSL expression increased over time, becoming more preponderant in week 16 in the SLE model, which could indicate that it is a crucial pathway for the development and progression of the pathology. In week 16, we observed a positive correlation between M-MDSC MHC-II and IFN-γ-producing CD4+ T cells.Keywords
Funding Information
- Agencia Nacional de Investigación y Desarrollo (ANID) (1231866, 11221280, 1231851, SA77210051, CN09_016/ICN 2021_045, P09/016-F, 21240988)
- Programa de Atracción e Inserción de Capital Humano Avanzado (PAI) (1231866, 11221280, 1231851, SA77210051, CN09_016/ICN 2021_045, P09/016-F, 21240988)
- Millennium Institute on Immunology and Immunotherapy (1231866, 11221280, 1231851, SA77210051, CN09_016/ICN 2021_045, P09/016-F, 21240988)
- Beca Doctorado Nacional ANID (1231866, 11221280, 1231851, SA77210051, CN09_016/ICN 2021_045, P09/016-F, 21240988)
This publication has 72 references indexed in Scilit:
- Myeloid-derived suppressor cells promote the formation of abdominal aortic aneurysms through the IL-3-ICOSL-ICOS axisBBA Advances, 2023
- Classical DC2 subsets and monocyte‐derived DC: Delineating the developmental and functional relationshipEuropean Journal of Immunology, 2023
- Myeloid-derived suppressor cells: Important communicators in systemic lupus erythematosus pathogenesis and its potential therapeutic significanceHuman Immunology, 2021
- Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic targetInflammopharmacology, 2021
- Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitisExperimental Neurology, 2016
- Co-stimulatory and Co-inhibitory Pathways in AutoimmunityImmunity, 2016
- Systemic Lupus ErythematosusDental Clinics of North America, 2013
- Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosusAutoimmunity Reviews, 2012
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen‐presenting cells and effector T cellsArthritis & Rheumatism, 2008